From: A case report of atypical anti-glomerular basement membrane disease
The day of admission | |
Parameter | Value-(normal range) |
(Urine) | |
  pH | 5 |
 Urine protein/creatinine ratio (g/gCr) | 1.42-(<  0.15) |
 Red blood cell (/HPF | 200–299-(< 5) |
 Oval fat body | – |
(Blood) | |
 White blood cell (/μL) | 5780-(3040–8540) |
 Neutrophil (%) | 73.2-(38.3–71.1) |
 Eosinophil (%) | 1.4-(0.2–7.3) |
 Basophil (%) | 0.5-(0.2–2.0) |
 Lymphocyte (%) | 20.4-(21.3–50.3) |
 Monocyte (%) | 4.5-(2.7–7.6) |
 Red blood cell (104 /μL) | 436-(378–499) |
 Hemoglobin (g/dL) | 12.8-(10.8–14.9) |
 Hematocrit (%) | 37.2-(35.6–45.4) |
 Platelet (104 /μL) | 32.1-(15.0–36.0) |
 AST(U/L) | 20-(13–33) |
 ALT(U/L) | 16-(8–42) |
 Total protein (g/dL) | 7.5-(6.7–8.3) |
 Serum albumin (g/dL) | 4.4-(4.0–5.0) |
 Blood urea nitrogen (mg/dL) | 13.8-(8–20) |
 Creatinine (mg/dL) | 1.44-(0.40–0.70) |
 eGFR (mL/min/1.73 m2) | 33-(> 90) |
 Na (mmol/L) | 137-(138–146) |
 K (mmol/L) | 3.9-(3.6–4.9) |
 Cl (mmol/L) | 101-(99–109) |
 Calcium (mg/dL) | 9.4-(8.6–10.4) |
 Phosphate (mg/dL) | 3.3-(2.5–4.7) |
 Uric acid (mg/dL) | 5.1–2.3–7.0) |
 Plasma glucose (mg/dL) | 90-(70–109) |
 Hemoglobin A1c (NGSP) (%) | 5.4-(4.6–6.2) |
 C-reactive protein (mg/dL) | 0.43-(<  0.20) |
 Immunoglobulin G (mg/dL) | 1152-(870–1700) |
 Immunoglobulin A (mg/dL) | 299-(110–410) |
 Immunoglobulin M (mg/dL) | 107-(46–260) |
 CH50 (IU/mL) | 53.2-(30–46) |
 C3 (mg/dL) | 135-(86–160) |
 C4 (mg/dL) | 36-(17–45) |
 Anti nuclear antigen | Negative |
 anti-neutrophilic cytoplasmic antibody | Negative |
 anti-glomerular basement membrane | Negative |
 HBs-Ag | Negative |
 HCV-Ab | Negative |
The day of the end of treatment | |
Parameter | Value-(normal range) |
(Urine) | |
 pH | 6.5 |
 Urine protein/creatinine ratio (g/gCr) | <LOD-(<  0.15) |
 Red blood cell (/HPF) | 1–4-(< 5) |
 Oval fat body | – |
(Blood) | |
 Blood urea nitrogen (mg/dL) | 11.4-(8–20) |
 Creatinine (mg/dL) | 0.75-(0.40–0.70) |
 eGFR (mL/min/1.73 m2) | 66-(> 90) |